Dr Hemal Mehta



This image has an empty alt attribute; its file name is image.png


Hemal Mehta is an expert in the fields of medical retina and
cataract surgery with extensive experience in general adult ophthalmology.


After reading medicine at Cambridge University in England, Hemal
Mehta carried out his clinical training at University College London. He completed
7 years of training in the London School of Ophthalmology with 3 of these years
at the world-famous Moorfields Eye Hospital with rotations in all major ophthalmology
subspecialties. He completed an 18-month medical retina fellowship at Sydney
Eye Hospital building strong research links in Australia. He was previously an
Ophthalmology Consultant at the Royal Free London NHS Foundation Trust specialising
in medical retina and cataract surgery as well as leading the retinal clinical
trials unit.

Medical Retina

Hemal Mehta is highly experienced in the diagnosis and management of
retinal conditions such as age-related macular degeneration, diabetic
retinopathy, and retinal vein occlusions. He is on the International Steering
Committee of the Fight Retinal Blindness! group that aims to record real-world outcomes
of intravitreal therapy to improve standards of care. He has published
extensively on the management of retinal disease providing original data and
also critically appraising evidence via the Cochrane Eye and Vision Group. He
was awarded the Royal College of Ophthalmologists Ethicon Award for work
streamlining diabetic retinopathy screening in the Northern Territory.

Cataract Surgery

Hemal Mehta is an experienced cataract surgeon having performed
thousands of operations. He is familiar with monofocal, toric, enhanced depth
of focus, trifocal and duet intraocular lenses and so can discuss the full
range of options available to patients undergoing cataract surgery.

Comprehensive Adult Ophthalmology

Hemal Mehta has experience dealing with a wide range of
ophthalmology presentations with commonly performed procedures including
intravitreal injections, cataract surgery, retinal laser, glaucoma laser
therapy, YAG laser capsulotomy, blepharitis treatment and surgery for eyelid


Hemal Mehta has lectured on the University College London Masters
Course in Ophthalmology and Royal College of Ophthalmologists Seminar on Retinal
Imaging. He supports extended skills training for local optometrists. He has taught
on common ophthalmology presentations for GPs at the Royal College of
Physicians. He has helped the Macular Society develop educational material for
patients and carers.


Hemal Mehta is at the forefront of retinal research globally. As
principal investigator, he recruited the first patient in Europe to the
PANOPTICA study, the first eyedrop for wet age-related macular degeneration to
show promise in early phase clinical trials. His higher research degree titled
“Novel endpoints in diabetic retinopathy clinical trials” is registered at
Cambridge University. He has academic affiliations with University College
London and Sydney University. He has been involved in designing and conducting
clinical trials of new longer lasting intravitreal injection therapies that
will soon be available to the public.